Skip to main content
57th ASAM Annual Conference Main banner
Final Program


Preview Program
Feedback

Focus Session

Retention Beyond Benchmarks: Patient-Centered Tele-MOUD Care in the Fentanyl Era

Sunday, April 26, 2026
10:15 AM - 11:30 AM PT
Location: Balboa, Level 2
This session presents groundbreaking results from more than 20,000 patients in a telehealth-only program, showing that high buprenorphine retention is not only possible but sustainable—with outcomes far exceeding national benchmarks. Presenters will unpack the care model behind these results, weaving together real-world data and patient voices to illuminate what keeps people engaged in treatment in the fentanyl era.

Learning Objectives:

Learners will be able to:
  • Compare retention outcomes in a large telehealth-only MOUD program to historical benchmarks, with attention to differences by buprenorphine transition pathway.
  • Identify program strategies (i.e. harm reduction, peer integration, tailored cadence, and non-punitive re-engagement) that support sustained retention in the fentanyl era.
  • Identify patient barriers to buprenorphine engagement and translate community insights into practical strategies to improve equity and continuity of care.
Disclosure(s):
Laura Monico, PhD: No financial relationships to disclose
Ayesha Appa, MD: Boulder Care: Employment (Ongoing)
Danielle Bellosi, NCPRSS, CPRC: No financial relationships to disclose
Elizabeth Bambury, MPH: No financial relationships to disclose
Jennifer K. Foreman, DNP, AGNP-C, WHNP-BC: No financial relationships to disclose
Melody Avila, DNP: No financial relationships to disclose
Stephen A. Martin, MD, EdM: No financial relationships to disclose